Perspective is leading human capital innovation in healthcare. In this period of disruption, healthcare and HR leaders are being pressed to redefine how they organize, recruit, develop, manage and engage their workforce. At Perspective, we leverage our ability to understand the strategic and operational priorities of our healthcare clients together with our insight into an evolving human capital landscape. As opposed to one-off projects, we identify ways to integrate more formally into our clients’ business with a unique set of services. We devise actionable human capital solutions resulting in measurable and sustained business impact. It is this integrated human capital™ approach that we leverage for the benefit of our clients.
With regard to our Board and Executive Search work, we are pleased to introduce our initial quarterly announcement. Looking back on 2017, it has proved to be an exciting year for both healthcare and human capital. Please see below, a list of several of our 2017 placements.
PLACEMENTS
Board Members
Mary Lynne Hedley, PhD, COO at TESARO | Director at bluebird bio
John Agwunobi, MD, former SVP, President, Health & Wellness at Walmart | Director at bluebird bio
Douglas Melton, PhD, Xander University Professor at Harvard University | Director at bluebird bio
Michael Minogue, Chairman, President & CEO at Abiomed | Director at Insulet
James Mullen, CEO of Patheon NV | Director at Insulet
Kevin Conroy, Chairman, President & CEO at Exact Sciences | Director at Epizyme
Eli Casdin, Managing Member, Casdin Capital | Director at Exact Sciences
Jacqualyn Fouse, PhD, President & COO at Celgene | Director at Incyte
Geno Germano, former Global Head, Innovative Pharma Business at Pfizer | Director at Bioverativ
Chief Executive Officer | Chief Operating Officer
Vince Angotti, CEO at AcelRx Pharmaceuticals
Jeffrey Hatfield, CEO at Zafgen
William McVicar, PhD, CEO at Flex Pharma
Joseph Ciaffoni, EVP and COO at Collegium Pharmaceutical
Christine Carberry, COO at Keryx Biopharmaceuticals
Finance
Tom Graney, CFO at Vertex Pharmaceuticals
Senthil Sundaram, CFO at Nightstar Therapeutics
Kory Wentworth, Vice President, Finance and Principal Accounting Officer at bluebird bio
Commercial
Jason Meyenburg, CCO at Vtesse
Andrew Robertson, VP & GM, Head of Europe at Sarepta Therapeutics
Business Development
Hugh Cole, CBO at Jounce Therapeutics
Aaron Schuchart, CBO at Aeglea BioTherapeutics
Jeremy Springhorn, PhD, CBO at Syros Pharmaceuticals
Devyn Smith, PhD, CSO, Head of Operations at Sigilon Therapeutics
Tanja Weber, VP, Business Development at Agios Pharmaceuticals
Ilan Zipkin, PhD, VP, Business Development at The Parker Institute for Cancer Immunotherapy
Paul Stead, PhD, VP, Business Development at Adaptimmune Therapeutics
Healthcare IT
John Marron, General Manager, Revenue Cycle Management at AdvancedMD
Research & Development
Lon Cardon, PhD, CSO at BioMarin Pharmaceutical
Tuyen Ong, MD, CDO at Nightstar Therapeutics
Technical Operations
Clive Patience, PhD, SVP, Technical Operations at Agios Pharmaceuticals